These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells. Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057 [TBL] [Abstract][Full Text] [Related]
5. Cathepsin S dominates autoantigen processing in human thymic dendritic cells. Stoeckle C; Quecke P; Rückrich T; Burster T; Reich M; Weber E; Kalbacher H; Driessen C; Melms A; Tolosa E J Autoimmun; 2012 Jun; 38(4):332-43. PubMed ID: 22424724 [TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro. Burster T; Beck A; Poeschel S; Øren A; Baechle D; Reich M; Roetzschke O; Falk K; Boehm BO; Youssef S; Kalbacher H; Overkleeft H; Tolosa E; Driessen C Immunology; 2007 May; 121(1):82-93. PubMed ID: 17302735 [TBL] [Abstract][Full Text] [Related]
7. Cathepsin A is expressed in primary human antigen-presenting cells. Reich M; Spindler KD; Burret M; Kalbacher H; Boehm BO; Burster T Immunol Lett; 2010 Feb; 128(2):143-7. PubMed ID: 19954752 [TBL] [Abstract][Full Text] [Related]
8. Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes. Burster T; Beck A; Tolosa E; Marin-Esteban V; Rötzschke O; Falk K; Lautwein A; Reich M; Brandenburg J; Schwarz G; Wiendl H; Melms A; Lehmann R; Stevanovic S; Kalbacher H; Driessen C J Immunol; 2004 May; 172(9):5495-503. PubMed ID: 15100291 [TBL] [Abstract][Full Text] [Related]
9. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing. Moss CX; Villadangos JA; Watts C Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009 [TBL] [Abstract][Full Text] [Related]
10. Application of a novel highly sensitive activity-based probe for detection of cathepsin G. Zou F; Schmon M; Sienczyk M; Grzywa R; Palesch D; Boehm BO; Sun ZL; Watts C; Schirmbeck R; Burster T Anal Biochem; 2012 Feb; 421(2):667-72. PubMed ID: 22178917 [TBL] [Abstract][Full Text] [Related]
11. Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus. Bowlus CL; Ahn J; Chu T; Gruen JR Cell Immunol; 1999 Sep; 196(2):80-6. PubMed ID: 10527559 [TBL] [Abstract][Full Text] [Related]
12. Asparaginyl endopeptidase: case history of a class II MHC compartment protease. Watts C; Matthews SP; Mazzeo D; Manoury B; Moss CX Immunol Rev; 2005 Oct; 207():218-28. PubMed ID: 16181339 [TBL] [Abstract][Full Text] [Related]
13. Glutathione depletion reveals impairment of antigen processing and inhibition of cathepsin activity by nitric oxide in antigen-presenting cells. Lemaire G; Guittet O; Vesin MF; Lepoivre M; Cottet MH Mol Immunol; 2009 Mar; 46(6):1100-8. PubMed ID: 19095306 [TBL] [Abstract][Full Text] [Related]
14. Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors. Katunuma N; Matsunaga Y; Himeno K; Hayashi Y Biol Chem; 2003 Jun; 384(6):883-90. PubMed ID: 12887055 [TBL] [Abstract][Full Text] [Related]
15. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Manoury B; Mazzeo D; Fugger L; Viner N; Ponsford M; Streeter H; Mazza G; Wraith DC; Watts C Nat Immunol; 2002 Feb; 3(2):169-74. PubMed ID: 11812994 [TBL] [Abstract][Full Text] [Related]
16. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells. Burster T; Reich M; Zaidi N; Voelter W; Boehm BO; Kalbacher H Biochem Biophys Res Commun; 2008 Dec; 377(4):1299-303. PubMed ID: 18996084 [TBL] [Abstract][Full Text] [Related]
17. Isolation of a membrane-associated cathepsin D-like enzyme from the model antigen presenting cell, A20, and its ability to generate antigenic fragments from a protein antigen in a cell-free system. Williams KP; Smith JA Arch Biochem Biophys; 1993 Sep; 305(2):298-306. PubMed ID: 8103981 [TBL] [Abstract][Full Text] [Related]
18. Cathepsin S inhibitors as novel immunomodulators. Thurmond RL; Sun S; Karlsson L; Edwards JP Curr Opin Investig Drugs; 2005 May; 6(5):473-82. PubMed ID: 15912960 [TBL] [Abstract][Full Text] [Related]
19. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense. Tausch L; Henkel A; Siemoneit U; Poeckel D; Kather N; Franke L; Hofmann B; Schneider G; Angioni C; Geisslinger G; Skarke C; Holtmeier W; Beckhaus T; Karas M; Jauch J; Werz O J Immunol; 2009 Sep; 183(5):3433-42. PubMed ID: 19648270 [TBL] [Abstract][Full Text] [Related]
20. Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins. Reich M; van Swieten PF; Sommandas V; Kraus M; Fischer R; Weber E; Kalbacher H; Overkleeft HS; Driessen C J Leukoc Biol; 2007 Apr; 81(4):990-1001. PubMed ID: 17261546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]